| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $80.0M | +67.1% |
| SG&A Expense | $21.8M | +31.4% |
| Operating Income | -$102.8M | -55.6% |
| Interest Expense | $1.3M | +42.4% |
| Income Tax | $0 | — |
| Net Income | -$102.7M | -50.4% |
| EPS (Basic) | -$2.14 | +29.8% |
| EPS (Diluted) | -$2.14 | +29.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.6M | -62.1% |
| Short-term Investments | $54.1M | +39.2% |
| Current Assets | $137.6M | -40.0% |
| Total Assets | $146.0M | -37.4% |
| Current Liabilities | $22.0M | +83.3% |
| Long-term Debt | $19.9M | +0.3% |
| Total Liabilities | $40.0M | +22.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98.5M | -71.0% |
| Capital Expenditures | $1.4M | -5.9% |
| Investing Cash Flow | -$18.1M | +55.3% |
| Financing Cash Flow | $708K | -99.7% |
| Free Cash Flow | -$99.9M | -69.1% |
| Stockholders' Equity |
| $106.0M |
| -47.2% |